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ABSTRACT Severalbroad-spectrummicrobicides,includingcellulosesulfate(CS),havepassedconventionalpreclinicalandphase
IclinicalsafetyevaluationandyethavefailedtoprotectwomenfromacquiringHIV-1inphaseII/IIItrials.Concernshavebeen
raisedthatcurrentpreclinicalalgorithmsaredeﬁcientinaddressingthecomplexityofthemicroﬂora-regulatedvaginalmucosal
barrier.Weappliedanovelmicroﬂora-colonizedmodeltoevaluateCSandhydroxyethylcellulose(HEC),whichisusedasa
“universalplacebo”inmicrobicidetrials.Cervicovaginalepithelialcultureswerecolonizedwithnormalvaginalmicroﬂoraiso-
lates representing common Lactobacillus species used as probiotics (L. acidophilus and L. crispatus)o rPrevotella bivia and
Atopobium vaginae, most prevalent in the disturbed microﬂora of bacterial vaginosis (BV). At baseline, all strains maintained
constantepithelium-associatedCFUswithoutinducingcytotoxicityandapoptosis.CSselectivelyreducedepithelium-associated
CFUs and (to a lesser extent) planktonic CFUs, most signiﬁcantly affecting L. crispatus. Inducing only minor changes in sterile
epithelialcultures,CSinducedexpressionofinnateimmunitymediators(RANTES,interleukin-8[IL-8],andsecretoryleukocyte
proteaseinhibitor[SLPI])inmicroﬂora-colonizedepithelia,mostsigniﬁcantlypotentiatingeffectsofbacteriacausingBV.Inthe
absence of CS, all bacterial strains except L. acidophilus activated NF-B, although IL-8 and RANTES levels were increased by
thepresenceofBV-causingbacteriaonly.CSenhancedNF-Bactivationinadose-dependentmannerunderallconditions,in-
cluding L. acidophilus colonization. HEC remained inert. These results offer insights into possible mechanisms of CS clinical
failure.Thebacteriallycolonizedcervicovaginalmodelrevealsuniqueaspectsofmicroﬂora-epithelium-druginteractionsand
innateimmunityinthefemalegenitaltractandshouldbecomeanintegralpartofpreclinicalsafetyevaluationofanti-HIVmi-
crobicidesandothervaginalformulations.
IMPORTANCE Thisreportprovidesexperimentalevidencesupportingtheconceptthatthevaginalmicroﬂoraregulatestheepi-
thelialinnateimmunityinaspecies-andstrain-speciﬁcmannerandthattopicallyappliedmicrobicidesmayalterboththebacte-
rialandepithelialcomponentsofthishomeostaticinteraction.Ourdataalsohighlighttheimportanceofdifferentiatingtheef-
fectsofbiomedicalinterventionsonepithelium-associatedversusconventionalplanktonicbacterialgrowthwhenassessing
vaginalmucosalhealthandimmunity.
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T
he healthy cervicovaginal mucosa represents an efﬁcient bar-
rieragainstsexuallytransmittedinfections(STIs)anddissem-
ination of pathogens. To preserve that barrier, the epithelial cells
of the female genital tract have developed tolerance of and mutu-
ally beneﬁcial interactions with the constituents of the normal
vaginal microﬂora while maintaining rapid innate immune re-
sponsestodanger-orpathogen-associatedmolecularpatterns(1–
6). Therefore, it is logical that any biomedical intervention strat-
egy designed to prevent STIs must preserve all aspects of the
natural barrier in order to be safe and effective for wide use by
women at risk. More speciﬁcally, in addition to preserving the
vaginal microﬂora, epithelial cell viability, and tissue integrity,
anti-HIVmicrobicidesmustbeespeciallydevoidofproinﬂamma-
tory activities, since mucosal inﬂammatory reactions recruit acti-
vatedCD4-positiveHIV-hostcellstothemucosa,promoteHIV-1
transepithelial penetration, and facilitate viral replication in in-
fectedcells(7–10).Currentpreclinicalsafetyalgorithmsusesterile
invitromodelstoassesstheproinﬂammatoryactivityofanti-HIV
microbicides;however,alimitationofthistraditionalapproachis
the absence of the physiological host-microﬂora interactions (8,
10). We describe a novel microﬂora-colonized cervicovaginal ep-
ithelialmodelforsafetyevaluationofmicrobicidesandothervag-
inal formulations. We applied this model to gain insights into the
mechanisms of cellulose sulfate (CS) failure as a topical vaginal
microbicide. Traditional phase I clinical studies have shown that
CS exhibits potent anti-HIV activity in vitro and have repeatedly
demonstrated that CS presents no safety concerns (11–16). How-
ever,theﬁrstlargephaseII/IIIstudyofCShadtobehalteddueto
failure to prevent and a trend to increase male-to-female HIV-1
transmission(17).Understandingthemechanismsunderlyingthe
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models that are more predictive are essential for further develop-
ment of successful anti-HIV microbicides.
RESULTS
Characteristics of the vaginal bacterial colonization model in
the absence of microbicide test products. The adherence of bac-
teria to epithelial cells in our model is visualized in Fig. 1A to D.
The transmission electron microscopy (TEM) images demon-
stratetheintimatecontactbetweenLactobacilluscrispatus(Fig.1A
and B) and Prevotella bivia (Fig. 1C and D) and the vaginal epi-
thelial cells, displaying a lack of morphological signs of apoptosis.
Similar observations (not shown) were obtained from adherence
studies of Lactobacillus acidophilus and Atopobium vaginae. All
bacterial strains studied (L. acidophilus, L. crispatus, P. bivia, and
A. vaginae) adhered to the epithelial cells in the absence of apo-
ptosis and cytotoxicity, as assessed by microscopy, caspase-3
cleavage(Fig.1E),andtrypanblueexclusiontests(Fig.1F),andat
reproducible CFU rates that were comparable between the bacte-
rialstrains(Fig.1GandH),andtheepithelialcell-associatedCFU
counts were stably maintained at constant rates over the experi-
mentalperiodof24to48h(Fig.1G).CFUcountswerecompara-
ble between the vaginal (Vk2/E6E7) and cervical (Ect1/E6E7) ep-
ithelial cell cultures (Fig. 1G and H) as well as between the
immortalized epithelial cell (Ect1/E6E7) monolayer model and
the polarized primary epithelial cell (VEC-100) tissue model
(Fig. 1H).
The direct effects of the different bacterial strains on epithelial
cell inﬂammatory activation under baseline conditions (in the
ﬁrst24hofcolonizationintheabsenceofCSandHEC)areshown
in Fig. 2. The bacterial strains were best distinguished by their
abilities to induce NF-B (Fig. 2A) activation and interleukin-8
(IL-8)production(Fig.2B).Atcomparablecolonizationrates,the
BV-associated bacteria induced the most signiﬁcant NF-B acti-
vationandthegreatestincreaseinIL-8levels,L.crispatusinduced
weaker NF-B activation and no IL-8, and L. acidophilus did not
induce any changes in either NF-B and IL-8 levels compared to
the medium control (no bacteria).
EffectsofCSandHECcompoundsonvaginalmicroﬂorasur-
vival and epithelial colonization. Since the primary polarized-
tissue model and the immortalized epithelial cell monolayer
model showed identical colonization patterns, the immortalized
cell line monolayer model, which is signiﬁcantly cheaper and eas-
ier to handle than the polarized-tissue model, was used to repeat-
edly assess effects of multiple-compound doses and various com-
pound batches on bacterial-epithelial interactions.
Fortheseexperiments,weusedadoserange(1to1,000g/ml)
that brackets the anti-HIV 50% effective concentration [EC50]o f
CS established in various in vitro assays (1 to 80 g/ml) (11, 16,
18). CS and HEC were nontoxic in this dose range, as shown for
both compounds in the vaginal monolayer model (Fig. 3A) and
for CS in both the monolayer immortalized and the polarized
primaryectocervicalcellmodels(Fig.3B).Microscopicevaluation
at the end of each bacterial coculture experiment also conﬁrmed
the lack of any morphological signs of cytotoxicity.
While HEC remained invariably innocuous with respect to
bacterial growth and colonization rates, CS showed distinct
bacterial-strain-dependent effects on epithelial cell-associated
and planktonic bacteria (cultured in the absence of epithelial
cells). CS reduced most signiﬁcantly, and in a dose-dependent
FIG 1 Colonization of human vaginal and cervical epithelial cells by vaginal
bacteria showed consistent bacterial association with epithelial cells in the
absence of apoptosis and cell toxicity. (A–D) Transmission electron micros-
copy image showing L. crispatus (A and B) and P. bivia (C and D) bacteria,
visualized as electron-dense bodies, adherent to the surface of vaginal epithe-
lial cells (Vk2/E6E7) with intact morphology after 24 h of colonization. The
barsandimagesrepresent500nmand4,800magniﬁcation(A),500nmand
6,800 magniﬁcation (B), 2 m and 1,900 magniﬁcation (C), and 500 nm
and 13,000 magniﬁcation, respectively. (E) Caspase-3 cleavage is presented
as percentages of cleaved total caspase-3 measured in vaginal epithelial cell
lysatesat24hafterbacterialcolonizationortreatmentwith1Mstaurospor-
ine. Bars represent means and standard errors of the means (SEM) of the
results determined with duplicate cultures used in two experiments. (F) Via-
bility of vaginal epithelial cells assessed by trypan blue inclusion tests at 5 days
postcolonization. Bars represent means and SEM of the results from triplicate
culture experiments. (G) CFU counts per square centimeter of epithelial cell
surface at 24 h and 48 h postcolonization of Vk2/E6E7 cells. Bars represent
meansandSEMoftheresultsdeterminedwithtriplicateculturesusedinthree
experiments. (H) Parallel assessment of CFU counts associated with primary
polarized (VEC-100) and immortalized monolayer (Ect1/E6E7) ectocervical
epithelial cells at 48 h postcolonization.
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lowed by planktonic L. crispatus (Fig. 5). P. bivia CFU levels were
lowered by CS in planktonic cultures to a greater degree than in
epithelial cell-associated cultures. A. vaginae did not survive well
in the absence of epithelial cells, and CS reduced its abundant
association with epithelial cells the least. Neither planktonic nor
epithelium-associated L. acidophilus was affected by CS.
EffectsofCSandHEContheimmunefunctionofcolonized
cervicovaginal epithelial cells. The effects of CS and HEC on se-
lected soluble innate-immunity mediators universally triggered
by inﬂammation are shown in Fig. 6. As with the ﬁndings seen at
24 h postcolonization (Fig. 2), at 48 h postcolonization both Lac-
tobacillus strains maintained a balanced noninﬂammatory base-
line in the absence of added compounds, as evidenced by the lack
ofsigniﬁcanteffectsonRANTES(Fig.6AandB),IL-8(Fig.6Cand
D),andsecretoryleukocyteproteaseinhibitor(SLPI)(Fig.6Eand
F) production by epithelial cells. In contrast to the lactobacilli,
A. vaginae signiﬁcantly increased both RANTES (P  0.05) and
IL-8 (P  0.01) production and showed a tendency to decrease
SLPI production, while P. bivia signiﬁcantly increased IL-8 pro-
duction (P  0.01).
Intheabsenceofbacteria,bothCS(Fig.6A,C,andE)andHEC
(Fig. 6B, D, and F) showed no signiﬁcant effects on levels of solu-
ble mediators measured in the cell culture supernatants of ecto-
cervicalcells(Fig.6)andvaginalcells(datanotshown).However,
CS induced signiﬁcant changes in IL-8, RANTES, and SLPI levels
when applied to bacterially colonized epithelial cells. Exposure to
CS (Fig. 6A), but not to HEC (Fig. 6B), across the entire dose
range increased RANTES levels nearly 2-fold in the presence of
all bacteria (P  0.01), with the highest levels achieved by en-
hancing the baseline effects of A. vaginae (Fig. 6A). Similarly, CS
exposure caused a dose-dependent increase in IL-8 levels in epi-
thelialcellscolonizedbyP.biviaandA.vaginae(P0.01)and,to
a lesser extent, in L. crispatus-colonized epithelia (P  0.01 with
CS at 1 g/ml; P  0.05 with CS at 10 and 100 g/ml) but not in
L. acidophilus-colonized epithelia (Fig. 6C). HEC exposure again
showed no effect (Fig. 6D). SLPI levels were increased in a dose-
dependent manner by CS exposure in the presence of all bacterial
strains(P0.01)(Fig.6E).ThistrendwasnotobservedwithHEC
(Fig. 6F).
To assess the effects of CS and HEC on NF-B activation, we
compared epithelial cells grown in the absence of bacteria to epi-
thelial cells colonized by L. acidophilus, which had no direct
NF-B activation effects, or by P. bivia, which had highest NF-B
activation potency in the ﬁrst 24 h of bacterial colonization, as
shown in Fig. 2. Again, at 48 h after colonization and 24 h after
compound exposure, in the absence of CS, L. acidophilus showed
no effect and P. bivia induced NF-B activation (P  0.001)
(Fig.7AandB).CSexposureinducedNF-Bactivationinadose-
dependent manner in the absence or presence of bacteria (P 
0.01), enhancing the proinﬂammatory effect of P. bivia (Fig. 6A).
In contrast, HEC remained inert under all conditions (Fig. 7B).
DISCUSSION
Our report provides experimental evidence supporting the con-
ceptthatthevaginalmicroﬂoraregulatestheepithelialinnateim-
FIG2 Proinﬂammatory properties of vaginal microﬂora strains at 24 h post-
colonization of epithelial monolayers in the absence of CS and HEC.
(A)NF-Bactivationassessedbyluciferaseactivity.Barsrepresentmeansand
SEM of the results determined with quadruplicate cultures in one of three
independent experiments. (B) IL-8 levels measured in the vaginal epithelial
cell culture supernatants. Bars represent means of the results determined with
duplicate cultures in one of three experiments. For comparisons of the results
determined with bacterially colonized cultures to those determined with con-
trol cultures without bacteria,  represents P  0.01 and  represents
P  0.001 (ANOVA [Dunnett’s multiple-comparison test]).
FIG 3 Cell viability determined by the MTT assay after 24 h of compound
exposure. (A) Immortalized vaginal epithelial cell monolayers (Vk2/E6E7)
exposed to the same dose range of cellulose sulfate and hydroxyethylcellulose;
(B) comparison of primary polarized (VEC-100) and immortalized mono-
layer (Ect1/E6E7) ectocervical epithelial cells exposed to cellulose sulfate. Val-
uesrepresentmeansandSEMoftheresultsdeterminedwithduplicatecultures
in one of three experiments.
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applied microbicides may interfere with this homeostatic balance
by altering both the bacterial and epithelial components of the
interaction.
The number of microbicide candidates surpasses the capacity
ofresearcherstotestthemallinexpensiveclinicaltrials.Theiden-
tiﬁcation of a successful microbicide product is critical to the ra-
tional selection of candidates through the employment of a com-
prehensive preclinical evaluation algorithm (8). This algorithm
includes assays to characterize physicochemical (P/C) properties
of active pharmaceutical ingredients and formulations, release
rates, speciﬁc antiviral activity, toxicity, pharmacokinetics, phar-
macodynamics, and efﬁcacy. In addition to the standard end-
points of cell and tissue toxicity, the peculiarities of the mucosal
transmissionofHIV(19)havehighlightedtheimportanceofeval-
uatinginﬂammatorymediatorssuchascytokinesandchemokines
(7, 9, 20). Most of those in vitro assays, however, employed cells
andtissuesfromthefemalegenitaltractintheabsenceofbacterial
colonization. Clearly, such cells and tissues are not representative
ofwhatoccursinvivo.Withtheaimofmoreaccuratelyreplicating
in vivo conditions, we devised a model based on bacterially colo-
nizedcervicovaginalcellsthatenablestheevaluationoftheimpact
of microbicide candidates on resident and pathogenic bacteria
and epithelial cells and their interactions.
TheBV-associatedbacterialspeciesP.biviaandA.vaginaetrig-
gered higher levels of IL-8 and NF-B activation, consistent with
clinical ﬁndings, which have associated variations in the vaginal
microﬂora with proinﬂammatory changes of the vaginal mucosal
environment and with changes in the local and systemic cytokine
levels in women with bacterial vaginosis (21–23). In agreement
with our results, a previous in vitro study performed using our
immortalized vaginal epithelial cell line (Vk2/E6E7) has shown
that short-term (6 h) inoculation with A. vaginae, but not with
L. crispatus, induced proinﬂammatory pathway activation and
upregulation of IL-8 and IL-6 (24). Our data are also consistent
with previous observations of in vivo strain-speciﬁc high-level in-
ﬂammatory properties of BV-associated microﬂora and low-level
or even anti-inﬂammatory properties of Lactobacillus spp. (22,
25). Our L. acidophilus strain is pending further genetic analysis
and characterization due to its promising noninﬂammatory pro-
ﬁle.
Additionally, an inverse clinical association has been found
between pathogenic Gram-negative bacteria and vaginal levels of
SLPI (22). SLPI is a pluripotent bactericidal protease inhibitor
essential for the vaginal barrier function, which is reduced in
women with BV and lower genital tract infections. Such reduc-
tions have been associated with an increased risk of HIV acquisi-
tion(22,26).SLPIhasHIV-inhibitoryproperties(27–35)andhas
FIG 4 Effects of cellulose sulfate and hydroxyethylcellulose (HEC) on bacterial colonization assessed after 24 h bacterial-epithelial coculture followed by 24h
exposure to compound test doses. Bars represent means and SEM of CFUs associated with duplicate vaginal epithelial cell cultures in two experiments with two
different batches of each test compound. For comparisons of the results determined with various compound doses to those determined with control medium,
* represents P  0.05, ** represents P  0.01, and *** represents P  0.001 (ANOVA [Dunnett’s multiple-comparison test]).
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failed microbicide candidate nonoxynol-9 (20).
Thecervicovaginalcellscolonizedwithbacteriarespondeddif-
ferently to CS and HEC. While HEC had no impact on bacterial
growth and colonization and produced no signiﬁcant changes in
the selected proinﬂammatory markers, CS selectively inhibited
growth and colonization by L. crispatus and A. vaginae, reduced
growth of P. bivia, albeit not signiﬁcantly, and had no effect on
L. acidophilus. CS also enhanced bacterially induced NF-B acti-
vation and increased the production of IL-8, RANTES, and SLPI
in response to the presence of bacteria.
OurdatasuggestthatCShasthecapacitytomodifycervicova-
ginal innate immunity and selectively change bacterial survival
rates in the context of microﬂora colonization. Theoretically, re-
ducing the adherence of A. vaginae and P. bivia may be beneﬁcial
for controlling BV. However, this inhibitory effect on L. crispatus
was more pronounced than the effect on the BV-causing bacteria
andpreviouslydeterminedclinicalevidencedoesnotdemonstrate
a signiﬁcant therapeutic effect of CS on BV (36). The selective
reduction of epithelium-associated L. crispatus populations may
be particularly worrisome, because L. crispatus is believed to con-
tributemorethanotherLactobacillusspeciestothestabilityofthe
normal vaginal microﬂora (37). Pyrosequencing analysis of the
vaginal microbiome of women treated with CS gel for 14 days
revealedaprevalenceofBV-associatedbacterialcommunitiesand
a reduction of populations of lactobacilli compared to the results
seenatbaselineandwithwomentreatedwithHEC-basedplacebo
gel (38). It is also possible that reduction of populations of
L. crispatus and less-harmful Gram-negative members in the mi-
croﬂora, via a direct effect or inhibition of epithelial adherence,
may lead to compensatory overgrowth of other vaginal bacteria.
Slightly increased numbers of Escherichia coli have been found in
women following a 14-day exposure to CS (15). CS was reported
to be inhibitory for most or all tested isolates of Gardnerella vagi-
nalis, Peptostreptococcus, Prevotella, Eubacterium, and Fusobacte-
rium at concentrations of 10 mg/ml in routine microbiological
assessments (39), but little is known about the possible mecha-
nism of action by which polyanionic compounds can interfere
withthegrowthofmicrobes.Previousstudieshaveshownthatthe
mechanism of antimicrobial activity for several STI-causing
pathogensbythesecompoundsmayinvolvereceptorantagonism
or mimicry during cell-cell fusion (11, 40).
The NF-B activation induced by CS, which peaked at low
doses, remains without explanation. Biphasic effects of cellulose
sulfate on in vitro HIV replication have been reported, with low
doses (1 to 3 g/ml) enhancing and higher doses inhibiting HIV
FIG 5 Direct effects of hydroxyethylcellulose (HEC) and cellulose sulfate on planktonic bacterial growth in the absence of epithelial cells. The bacterial
suspensions that were used for epithelial colonization were simultaneously mixed with equal volumes of compound doses and incubated under anaerobic
conditions for 24 h, followed by agar plating for enumeration of CFUs. Note that A. vaginae did not survive well in the absence of epithelial cells, whereas it
maintained a stable colonization rate in the vaginal and cervical epithelial cells, as shown in Fig. 1G and H and 4D. Bars represent means and SEM of the results
determined with triplicate cultures in two independent experiments performed with two different batches of test compounds. For comparisons of the results
determinedwithvariouscompounddosestothosedeterminedwithcontrolmedium,***representsP0.001(ANOVA[Dunnett’smultiple-comparisontest]).
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driven activation of NF-B response elements in the HIV long
terminalrepeat(LTR),asseeninourcervicovaginalepithelialcell
model. NF-B upregulates inﬂammatory gene products such as
IL-8 that increase the HIV infection risk; at the same time, how-
ever,italsoupregulatesinnateimmunitygeneproducts,e.g.,SLPI
and RANTES, that could potentially reduce the risk of HIV. SLPI
upregulation induced by high doses of CS may have beneﬁcial
effects and may counteract the negative role of NF-B upregula-
tion. The clinical signiﬁcance of these phenomena remains to be
ascertained in future studies (42). Similarly, the functional signif-
icance of the increase in the level of RANTES may be twofold.
RANTES is a T-cell chemokine that attracts CD4 and HIV host
cells to the epithelial surface, thus increasing the risk of infection
(43). At the same time, it can compete with HIV for CCR5 core-
ceptor usage, thus playing a protective role. CCR5 blockade has
been used as a target mechanism for anti-HIV drug development
(44–49). Increased levels of RANTES, such as have been observed
in the cervicovaginal mucosa of HIV-resistant sex workers, have
been interpreted as representing part of the innate immune bar-
rier conferring protection in these women (50); however, they
may also represent an unrecognized sign of disturbed microﬂora
balance in these women (26, 51). Interestingly, the level of RAN-
TES was increased most signiﬁcantly by A. vaginae, which is vir-
tually absent from the normal microﬂora but is found in BV mi-
croﬂora (52).
In conclusion, the ﬁndings in our physiologic model of
microﬂora-epithelialcellinteractionsprovideexperimentalproof
for the role of bacterial colonization in regulating the vaginal im-
mune environment. This model should be further explored to
better deﬁne its value in predicting clinically undesirable mucosal
alterations by vaginal products.
Theﬁndingsofthisstudyfurtherconstituteanexampleofhow
a microbicide may interfere with microbial-epithelial interac-
tions. Taken together, they allow us to put forth a hypothesis to
explain why administration of CS failed to protect women from
FIG 6 Compound-induced innate immune responses after 24 h of colonization with vaginal bacterial strains followed by 24 h of exposure to cellulose sulfate
orhydroxyethylcellulose.BarsrepresentmeansandSEMofRANTES(AB),IL-8(CD),andSLPI(EF)levelsmeasuredinsupernatantsfromduplicateectocervical
epithelialcellculturesinoneofthreeexperimentswiththreedifferentbatchesofcellulosesulfate.Thedashedlinerepresentsmedium-controlbasallevelsinthe
absenceofbacterialcolonization.Similarresultswereobtainedwiththevaginalepithelialcells(datanotshown).Forcomparisonsoftheresultsdeterminedwith
variouscompounddosestothosedeterminedwithcontrolmediumwithineachtreatmentgroup(shownatthebottom),*representsP0.05and**represents
P  0.01; for comparisons of the results determined with bacterially colonized cultures to those determined with cultures without bacteria for each compound
dose,  represents P  0.05 and  represents P0.01 (ANOVA [Dunnett’s multiple-comparison test]).
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used. Through the comparisons of CS to HEC, a nonsulfated cel-
lulosic derivative that is the main polymer of the “universal” pla-
cebo used in microbicide trials, the data provide an insight into
possiblemechanismsbywhichCSmaydisturbthevaginalmicro-
biomeandthephysiologicalinteractionsofthesebacteriawiththe
cervicovaginal mucosa, thereby increasing its susceptibility to
HIV-1 infection.
In a more general aspect, our data highlight the importance of
differentiating effects of biomedical interventions on epithelium-
associated versus conventional planktonic bacterial growth when
assessing mucosal health and immunity.
MATERIALS AND METHODS
Test agents. Cellulose sulfate was obtained from CONRAD (Arlington,
VA; manufactured by Patheon, Research Triangle, NC), and hydroxyeth-
ylcellulose (HEC) was purchased from Hercules, Hopewell, VA. Endo-
toxin contamination of each reagent and compound was ruled out using
the Endosafe system (Charles River Laboratories, Charleston, SC) based
on the Limulus amoebocyte lysate (LAL) test (53) at a sensitivity of 0.05
endotoxin units (EU)/ml. A negative endotoxin test result was a require-
ment for reagent use.
Epithelial cell culture. Human immortalized endocervical (End1/
E6E7), ectocervical (Ect1/E6E7), and vaginal (Vk2/E6E7) epithelial cell
lines, whose differentiation patterns and immune responses closely re-
semble those of their normal tissues of origin (1, 2, 4, 20, 54–56), were
grown as monolayers in antibiotic-free keratinocyte serum-free medium
(KSFM) (Invitrogen, Carlsbad, CA) supplemented with bovine pituitary
extract, epidermal growth factor, and calcium chloride as described pre-
viously (55). The physiologic properties of the monolayer cultures were
comparedtothoseofpolarizedthree-dimensional(3-D)VEC-100tissues
derived from primary human ectocervical epithelial cells grown using
permeable-membrane support (MatTek Corporation, Ashland, MA),
which were previously shown to resemble the bactericidal and immune
properties of normal tissues of origin (57, 58). The VEC-100 tissues were
maintained in antibiotic-free medium (MatTek).
Bacterialstrainsandcolonizationassays.TheLactobacillusacidophi-
lus, Lactobacillus crispatus, and Prevotella bivia isolates were originally
collectedfromvaginalswabsamplesfromhealthywomenparticipatingin
a vaginal microﬂora research study (59). Atopobium vaginae (BAA-55)
was acquired from the American Type Culture Collection (ATCC, Ma-
nassas, VA). We chose the L. acidophilus strain as a representative of the
broader L. acidophilus homology group of commensal lactic acid-
producing bacteria because of its known probiotic properties (60) and
because L. acidophilus is one of very few taxa that have thus far shown
promising randomized clinical trial evidence for microbiological and
clinical cure of BV (61). L. crispatus was chosen for its prevalence in the
healthy human vaginal microﬂora and its pharmaceutical use as a probi-
otic (37, 60, 62), and P. bivia and A. vaginae were chosen for their preva-
lence as BV-associated microﬂora (37, 52, 63). The bacterial isolates were
identiﬁed using phenotypic characteristics and established criteria (64),
and the identiﬁcations were conﬁrmed using the Microbial Identiﬁcation
System for long-chain fatty acid analysis (MIDI Inc., Newark, NJ). For
epithelialcolonization,bacterialsuspensionswerepreparedinantibiotic-
free KSFM and added at 2.2  106 CFU/cm2 to conﬂuent epithelial sur-
faces at a 10:1 bacterial cell/epithelial cell ratio. This multiplicity of infec-
tion (MOI) was the best approximation we could make based on the
average values determined for recovery of vaginal bacteria per gram of
vaginalﬂuid(59,65,66).Ourpreliminarysetupincludedcomparisonsof
doses administered over a range of MOIs at 4-h incubation intervals, and
we saw consistent adherence rates that did not increase when higher CFU
numbers were added to the vaginal epithelial surface (67). The bacterial-
epithelial cocultures were then incubated using an orbital shaker at 35°C
under anaerobic conditions and an AnaeroPack system (PML Microbio-
logicals, Wilsonville, OR).
After 24 h, the loosely attached bacteria were removed by two washes
in sterile Dulbecco’s phosphate-buffered saline (PBS) (Invitrogen by Life
Technologies,Carlsbad,CA),followedby24-hexposurestovariousdoses
of test compounds in antibiotic-free KSFM. At the end of this period,
supernatants were collected for soluble mediators and the epithelial cells
were washed two times with sterile PBS and used for assessment of epi-
thelial viability, CFU counts, caspase-3 cleavage, and NF-B activation as
described below.
Transmissionelectronmicroscopy.Tovisualizebacterialattachment
to epithelial cells in our model and to assess morphological signs of apo-
ptosis, Vk2/E6E7 cells were seeded on Aclar embedding ﬁlm (Ted Pella
Inc.,Redding,CA).After24hofbacterialcolonizationwith2.2106bac-
teria/cm2,theepithelialmonolayerswerewashedwithcoldPBSandﬁxed
f o r3ha troom temperature in 2% formaldehyde–2.5% glutaraldehyde–
0.1 M sodium cacodylate buffer (pH 7.4) followed by 30 min of incuba-
tion in 1% osmium tetroxide–1.5% potassium ferrocyanide, washing in
PBS, and 30 min of incubation in aqueous uranyl acetate (all from Elec-
tronMicroscopyScience,Hatﬁeld,PA).ThecellswerenextwashedinPBS
and dehydrated in 50%, 70%, 95%, and 100% alcohol for 5 min per
gradient. Cells were embedded in plastic by inverting an Epon-araldite
gelatin capsule over the sample and then polymerized at 60°C for 24 h.
Ultrathin sections were cut using a Reichert Ultracut-S microtome (Lecia
Microsystems, Buffalo Grove, IL), applied to lead citrate-stained copper
grids, and examined using a TecnaiG2 Spirit BioTWIN transmission
electron microscope (FEI Company, Hillsboro, OR) at a primary magni-
ﬁcation of 1,000 to 30,000. Images were recorded with an AMT 2k
charge-coupled-device (CCD) camera (Advanced Microscopy Tech-
niques, Woburn, MA).
Testsofepithelialcellviability.Toassesscompoundcytotoxicity,we
used the CellTiter 96 MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
FIG 7 Compound-induced NF-B activation after 24 h of bacterial coloni-
zation followed by 24 h of exposure to cellulose sulfate (A) or hydroxyethyl-
cellulose (B). Bars represent means and SEM from luciferase activity determi-
nations performed with duplicate cultures in one of three experiments with
three different batches of each test compound. For comparisons of the results
determined with various compound doses to those determined with control
medium within each treatment group (shown at the right), ** represents P 
0.01; for comparisons of the results determined with bacterially colonized
cultures to those determined with cultures without bacteria for each com-
pound dose,  represents P  0.01 and  represents P  0.001
(ANOVA [Dunnett’s multiple-comparison test]).
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talized cell lines and the VEC-100 model as previously described (20, 54,
56,58).Inthisassay,mitochondriainviablecellsconverttheyellowMTT
into a blue formazan product. The colorimetric reaction is measured by
determiningabsorbanceat570nmwithareferencewavelengthat630nm.
Absorbance was read using a Victor2 counter with Wallac 2.01 software
(PerkinElmer Life Sciences). Viability was quantiﬁed as the percentage of
the total cell numbers seen under each set of conditions of compound
treatmentversustheaverageopticaldensity(OD)measuredforuntreated
(medium alone) control cells.
Inaddition,weusedthetrypanblueassaytoenumerateviableepithe-
lial cells in the bacterially colonized epithelial cultures and for a quantita-
tive assessment of cleaved versus total caspase-3 amounts as a marker of
epithelial cell apoptosis (Meso Scale Discovery [MSD], Gaithersburg,
MD).
For the trypan blue assay, epithelial cells were dislodged with 0.1%
trypsin–0.01% EDTA (Invitrogen by Life Technologies, Carlsbad, CA)
as described previously (55) at 5 days after bacterial colonization. Upon
neutralization with 10% fetal calf serum in DMEM-F12 medium
(Invitrogen),theepithelialsuspensionsweremixedwithequalvolumesof
10% trypan blue (Fisher Scientiﬁc, Pittsburgh, PA) followed by enumer-
ation of viable cells (no color) and dead cells (blue color due to dye up-
take) by the use of a standard hemocytometer microscope.
For the cleaved and total caspase-3 assays, epithelial cultures were
incubated with medium control or bacteria for 24 h. The proapoptotic
agentstaurosporine(SigmaAldrich,St.Louis,MO)wasaddedat1Mto
serve as a positive control. At the end of this period, epithelial cell mono-
layerswerelysedinMSD-providedTrislysisbufferandproteaseinhibitor
cocktail per manufacturer’s instructions and 25 l of each lysate was
loadedintotheMSD2-spotassayplatesforsimultaneousmeasurementof
total and cleaved caspase-3 levels. Caspase-3 is a downstream proapop-
totic effector caspase, regulating multiple proteins with key functions in
apoptotic signaling (68).
CFU enumeration. Viable bacteria associated with epithelial cells as
well as planktonic bacterial growth in epithelial cell-free medium were
assessed by CFU counts after 24 h of epithelial colonization with bacteria
and 24 h of incubation with test compounds. For assessment of epithelial
cell-associatedCFUs,attheendofeachincubationperiod,epithelialcells
were washed twice with ice-cold PBS and hypotonically lysed in ice-cold
HyPure water (Fisher Scientiﬁc, Pittsburgh, PA) for 15 min, followed by
adjustment of osmolarity with PBS (concentrated 2-fold) and plating on
Brucella anaerobic agar with 5% sheep blood (BD, Franklin Lakes, NJ).
The plates were incubated in an anaerobic chamber (Coy Laboratory
Products, Inc., Grass Lake, MI) containing an atmosphere of 10% hydro-
gen, 10% carbon dioxide, and 80% nitrogen at 37°C for 24 to 72 h (until
visible colonies were formed), followed by CFU counting. For the assess-
ment of direct effects of compounds on planktonic bacteria, the same
solutions of compounds that were tested in the colonized model were
mixed with bacterial suspensions in the absence of epithelial cells and
incubated under the same anaerobic conditions for 24 h followed by agar
plating and CFU counts performed as described above.
NF-B luciferase assay. Epithelial cells seeded at 1  104 cells/well in
96-well plates were transfected with pHTS–NF-B ﬁreﬂy luciferase re-
porter vector (Biomyx Technology, San Diego, CA) by the use of a gene-
juice transfection protocol as described previously (4). After supernatant
removal at the end of the test compound treatment period, epithelial
cells were lysed in GloLysis buffer and luciferase activity was determined
using a Bright-Glo luciferase assay system per manufacturer instructions
(Promega, Madison, WI). Luminescence signal was measured using a
Victor2 1420 multilabel microplate counter with Wallac 2.01 software
(PerkinElmer Life Sciences, Boston, MA).
Quantitation of innate immunity mediators. Concentrations of
the chemokines interleukin-8 (IL-8) and RANTES in cell culture super-
natantsweremeasuredusingelectrochemiluminescence(ECL)assaysand
a Sector Imager 2400 reader (MSD, Gaithersburg, MD). SLPI levels were
measured using a Quantikine enzyme-linked immunosorbent assay
(ELISA)(R&DSystems,Minneapolis,MN)andtheVictor2reader.Com-
pound interference with the cytokine detection assays was ruled out by
spikingknownamountsofrecombinantcytokinestandardsincompound
solutions prepared in cell culture medium and measuring percentages of
cytokine recovery from compound-supplemented medium versus the
percentages determined for the plain medium control as described previ-
ously (9).
Statistical analysis. One-way analysis of variance (ANOVA; Bon-
ferroniorDunnett’smultiple-comparisonanalyses)wasperformedusing
GraphPad Prism version 4.00 for Windows (GraphPad Software, San
Diego, CA). P values of 0.05 were considered signiﬁcant.
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